NightWatch

Leiden, Netherlands Founded: 2013 • Age: 13 yrs
Wearable armbands for detecting epileptic seizures during sleep are offered.

About NightWatch

NightWatch is a company based in Leiden (Netherlands) founded in 2013 by Mark Bloemendaal, Asmund Tielen, and Asmund Tielens. NightWatch offers products and services including NightWatch Device. NightWatch operates in a competitive market with competitors including Empatica, NeuroPace, Seer, Cadence Neuroscience and Epitel, among others.

  • Headquarter Leiden, Netherlands
  • Founders Mark Bloemendaal, Asmund Tielen, Asmund Tielens
  • Sectors
    Healthcare
    Technology
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website nightwatchepilepsy.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Livassured B.V.
Key Metrics
  • Latest Funding Round
    $55.29K (USD), Grant

    Mar 2020

  • Investors

Products & Services of NightWatch

NightWatch offers a comprehensive portfolio of products and services, including NightWatch Device.

NightWatch Device
Medical Device

Wearable system for detecting and alerting epileptic seizures during sleep.

Apps and channels of NightWatch

its YouTube channel NightWatch Epilepsy seizure detection has 988 subscribers and 30 videos.

NightWatch Epilepsy seizure detection
YouTube 988 subscribers 30 videos Film & Animation
Open channel

Videos from NightWatch

The most watched videos on NightWatch's YouTube channel, NightWatch Epilepsy seizure detection (988 subscribers). Click a video to play it here.

NightWatch - Sistema de detección de ataques de epilepsia
10.7K views
NightWatch Epilepsie Erkennungssystem - Video zur Inbetriebnahme
8.5K views
NightWatch - Détection des crises d’épilepsie - Proches et soignants
4.3K views
NightWatch - Détection des crises d’épilepsie
4K views

More on NightWatch Epilepsy seizure detection.

Funding Insights of NightWatch

  • Total Rounds 3
  • Last Round Grant — $55,285
  • Investors Count 5

All 3 funding rounds of NightWatch with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2020$55,285Grant––
Dec 2019$55,095Grant––
Sep 2018–Series A–Oost NL, Health Innovations
–
Valuation history

5 investors in total: 5 institutional.

Investors in NightWatch

NightWatch has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Oost NL and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
–eicfund.euBrussels, Belgium
Sector-agnostic VC firm investing in geographies such as the Netherlands
2003oostnl.nlApeldoorn, Netherlands
Health Innovations is focused on investing in healthcare improvements.
2007healthinnovations.nlNetherlands
Holland Capital is engaged in venture and growth investments.
1981hollandcapital.nlAmsterdam, Netherlands
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for NightWatch

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of NightWatch

4 people are tracked at NightWatch (4 in leadership).

NameRoleGroup
Mark Bloemendaal
Co-FounderLeadership
Asmund Tielen
Co-Founder & CTOLeadership
Asmund Tielens
Co-FounderLeadership
Jeroen Van Den Hout
CEOLeadership
Premium access

Complete people profiles for NightWatch

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of NightWatch

3 dated milestones of NightWatch across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded NightWatch is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $55K.

Competitors of NightWatch

NightWatch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Empatica, NeuroPace, Seer, Cadence Neuroscience and Epitel, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
empatica.com2011Milano, Italy$30.95M–
Developer of a wrist band to monitor physiological signals
neuropace.com1997United States$263.56M184
Implantable neurostimulation systems for epilepsy treatment are developed.
seer.bio2017San Francisco, United States$127.5M89
Proteomics platform developed for early cancer and neurological disease detection.
cadenceneuro.com2016Redmond, United States$41.03M–
Medical devices for treating neurological disorders like epilepsy are developed.
epitel.com2007Salt Lake, United States$12.5M–
Wearable EEG system for epilepsy monitoring and control is provided.
neurava.com2019West Lafayette, United States$5.78M–
Remote monitoring platform for epilepsy patients
engagetherapeutics.com2017Summit, United States$30.6M–
Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures
neuroeventlabs.com2015Tampere, Finland$6.59M–
AI-based seizure monitoring
Premium access

Detailed competitors of NightWatch

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of NightWatch

The website of NightWatch (nightwatchepilepsy.com) receives about 12.1K visits a month.

  • Monthly visits
    12.1K
Similar websites

Websites whose visitors overlap most with NightWatch. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
epikurier.de
epikurier.de
100%
–#3,542,939–
empatica.com
69%
80.3K#362,527View details
cpapeuropa.com
cpapeuropa.com
68%
–#790,906–
samialert.com
30%
680.7K#1,741,060View details
bascom-kameras.de
bascom-kameras.de
27%
–#1,135,489–

Latest news on Nightwatch

Premium access

Complete news archive for NightWatch

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to NightWatch

10 companies that operate in the same segment as NightWatch (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about NightWatch

NightWatch was founded in 2013 and raised its 1st funding round 5 years after it was founded.

NightWatch is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.

Jeroen Van Den Hout is the current CEO of NightWatch.

NightWatch was founded in 2013 in Leiden, Netherlands, within the health technology sector. Wearable armbands are developed to monitor heart rate and motion during sleep, enabling detection of tonic and tonic-clonic epileptic seizures. Wireless alerts are transmitted to a base station to notify caregivers of potential risks. The focus remains on supporting epilepsy management through this non-invasive device for overnight use.

NightWatch's top competitors include Empatica, NeuroPace and Seer.

NightWatch offers NightWatch Device.

NightWatch has 5 investors. Key investors include European Union, Oost NL, EIC Fund, Health Innovations, and Holland Capital.

NightWatch operates through Livassured B.V..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available